Open Access Articles

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target

, 2017; 13(2): 76 - 88

Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*




In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells

, 2017; 13(2): 129 - 136

Ade Arsianti*, Fadilah Fadilah, Kusmardi Kusmardi, Gede Y. Sugiarta, Hiroki Tanimoto and Kiyomi Kakiuchi




Non-Melanoma Skin Cancer – Overview

, 2016; 12(3): 142 - 151

Kurian Joseph




Roles of Tumor Microenvironment in Hepatocelluar Carcinoma

, 2015; 11(2): 82 - 93

Haeng R. Seo




Trends in Malignant Glioma Monoclonal Antibody Therapy

, 2015; 11(2): 102 - 118

Ivan Chekhonin and Olga Gurina




Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers

, 2013; 9(4): 265 - 277

Ana Paula Delgado, Pamela Brandao, Sheilin Hamid and Ramaswamy Narayanan




Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine

, 2010; 6(2): 126 - 137

Nathalie Garcon and Oberdan Leo




Clinical Development of MET Targeted Therapy For Human Cancer

, 2009; 5(4): 261 - 270

Nima Tirgan, Zhe Tang and Patrick C. Ma




Tumor Systems Need to be Rendered Usable for a New Action-Theoretical Abstraction: The Starting Point for Novel Therapeutic Options

, 2009; 5(4): 232 - 242

Albrecht Reichle




Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy

, 2009; 5(2): 111 - 121

Nagendra K. Prasad




Runx1/AML1 is a Guardian of Hematopoietic Stem Cells

, 2008; 4(3): 188 - 195

Lena Motoda, Motomi Osato and Yoshiaki Ito




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science